Solute carrier family 22 member 1
| GO Term | Evidence Code | Reference |
|---|---|---|
| xenobiotic metabolic process | ||
| neurotransmitter transport | ||
| obsolete serotonin transport |
|
|
| establishment or maintenance of transmembrane electrochemical gradient | ||
| obsolete organic cation transport |
|
|
| GO Term | Evidence Code | Reference |
|---|---|---|
| plasma membrane | ||
| plasma membrane | ||
| plasma membrane | ||
| basal plasma membrane | ||
| basal plasma membrane |
| GO Term | Evidence Code | Reference |
|---|---|---|
| acetylcholine transmembrane transporter activity | ||
| acetylcholine transmembrane transporter activity | ||
| neurotransmitter transmembrane transporter activity | ||
| neurotransmitter transmembrane transporter activity | ||
| dopamine:sodium symporter activity |
| Position | Description | PubMed ID | GlyTouCan ID | Source |
|---|---|---|---|---|
| 71 |
|
|
| Pathway Name | Organism |
|---|---|
| Abacavir transmembrane transport | Homo sapiens |
| Ciprofloxacin ADME | Homo sapiens |
| Neurotransmitter clearance | Homo sapiens |
| Norepinephrine Neurotransmitter Release Cycle | Homo sapiens |
| Organic cation transport | Homo sapiens |
| SLC-mediated transport of neurotransmitters | Homo sapiens |
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
This work is licensed under Creative Commons Attribution 4.0 International
GlyCosmos Portal v4.5.0
Last updated: April 6, 2026